MACLEODS PHARMA USA, INC recalls
2 notices naming MACLEODS PHARMA USA, INC as the recalling firm, since April 1, 2026. A notice covers specific products and lots, not every product of the firm.
Hazard and remedy text is quoted from the agency, unedited. The tag names the kind of risk with a word from that text. Every notice links to its official page.
Dissolution
MACLEODS PHARMA USA, INC: Olmesartan Medoxomil
Hazard (FDA): Failed Dissolution Specifications.
FDAMedicines
MACLEODS PHARMA USA, INC: Levothyroxine Sodium Tablets USP 150 mcg
Hazard (FDA): Subpotent Drug
FDAMedicines